| Three‐dimensional cell culture model utilization in cancer stem cell research ZF Bielecka, K Maliszewska‐Olejniczak, IJ Safir, C Szczylik, ... Biological Reviews 92 (3), 1505-1520, 2017 | 134 | 2017 |
| The role of the cell–cell interactions in cancer progression K Kamińska, C Szczylik, ZF Bielecka, E Bartnik, C Porta, F Lian, ... Journal of cellular and molecular medicine 19 (2), 283-296, 2015 | 134 | 2015 |
| Mechanisms of acquired resistance to tyrosine kinase inhibitors in clear-cell renal cell carcinoma (ccRCC) Z F Bielecka, A M Czarnecka, W Solarek, A Kornakiewicz, C Szczylik Current signal transduction therapy 8 (3), 219-228, 2013 | 82 | 2013 |
| Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approaches MI Khan, ZF Bielecka, MZ Najm, E Bartnik, JS Czarnecki, AM Czarnecka, ... International journal of oncology 44 (2), 349-363, 2014 | 78 | 2014 |
| Insulin and IGFs in renal cancer risk and progression W Solarek, AM Czarnecka, B Escudier, ZF Bielecka, F Lian, C Szczylik Endocr Relat Cancer 22 (5), R253-R264, 2015 | 61 | 2015 |
| Mammalian target of rapamycin inhibitors resistance mechanisms in clear cell renal cell carcinoma A Kornakiewicz, W Solarek, Z F Bielecka, F Lian, C Szczylik, ... Current signal transduction therapy 8 (3), 210-218, 2013 | 33 | 2013 |
| Genomic Analysis as the First Step Toward Personalized Treatment in Renal Cell Carcinoma ZF Bielecka, AM Czarnecka, CA Szczylik Name: Frontiers in Oncology 4, 194, 2014 | 30 | 2014 |
| Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells K Maliszewska-Olejniczak, KK Brodaczewska, ZF Bielecka, W Solarek, ... Cytotechnology 71, 149-163, 2019 | 25 | 2019 |
| Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells ZF Bielecka, A Malinowska, KK Brodaczewska, A Klemba, C Kieda, ... Cell & Bioscience 7, 1-18, 2017 | 25 | 2017 |
| Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance KK Brodaczewska, ZF Bielecka, K Maliszewska‑Olejniczak, C Szczylik, ... Oncology Reports 42 (5), 1878-1892, 2019 | 24 | 2019 |
| Three-dimensional cell culture model utilization in renal carcinoma cancer stem cell research K Maliszewska-Olejniczak, KK Brodaczewska, ZF Bielecka, ... Epithelial Cell Culture: Methods and Protocols, 47-66, 2018 | 17 | 2018 |
| Optimal 3D cell culture model of human renal carcinoma stem-like cells. AM Czarnecka, ZF Bielecka, KK Brodaczewska, K Maliszewska, ... MOLECULAR BIOLOGY OF THE CELL 27, 2016 | | 2016 |
| Renal cell cancer tumor initiating cells as molecular regulators of disease progression AM Czarnecka, MI Khan, ZF Bielecka, D Matak, KK Brodaczewska, ... ANNALS OF ONCOLOGY 26, 6-6, 2015 | | 2015 |
| 23P Renal cell cancer tumor initiating cells as molecular regulators of disease progression AM Czarnecka, MI Khan, ZF Bielecka, D Matak, KK Brodaczewska, ... Annals of Oncology 26, ix1, 2015 | | 2015 |
| Different protein expression occurs between TKI-resistant and untreated human kidney cancer stem-like cells in normoxia and hypoxia ZF Bielecka, P Krasowski, D Matak, J Piwowarski, E Grzesiuk, C Szczylik, ... FEBS JOURNAL 282, 368-369, 2015 | | 2015 |
| Molecular events regulating clear cell renal cell cancer resistance to tyrosine kinase inhibitors. AM Czarnecka, ZF Bielecka, K Kaminska, D Matak, L Szymanski, MI Khan, ... Journal of Clinical Oncology 33 (15_suppl), e15600-e15600, 2015 | | 2015 |
Anna M. CzarneckaMaria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.在 coi.pl 的电子邮件经过验证
